Browse 313 market data Tables and 64 Figures spread through 315 Pages and in-depth TOC on "Cancer Tumor Profiling Market - Global Forecast to 2031"Cancer Tumor Profiling Market Size & Forecast:Market Size Available for Years: 2026-20312026-2031 2026 Market Size: USD 12.02 billionUSD 12.02 billion 2031 Projected Market Size: USD 19.87 billionUSD 19.87 billion CAGR (2026-2031): 10.6%Cancer Tumor Profiling Market Trends & Insights:Cancer tumor profiling is shifting from tissue-dominant, single-marker, and centralized testing toward integrated precision-oncology workflows based on NGS comprehensive genomic profiling, liquid biopsy, longitudinal monitoring, AI-enabled interpretation, digital pathology, and multi-omics. Assays, kits, reagents, and consumables accounted for the largest share of the global cancer tumor profiling market, by offering, in 2025. Based on offering, the cancer tumor profiling market is segmented into instruments & systems; assays, kits, reagents, and consumables; clinical tumor profiling testing services; and biopharmaceutical, clinical-trial, and companion diagnostic services. Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1250Solid tumors accounted for the largest share of the cancer tumor profiling market, by cancer type, in 2025. The cancer tumor profiling market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.